Skip to content

EBITDA at other companies

Schrodinger logo
SchrodingerSDGR
-$47.32M+4.0%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$108.83M+36.7%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$50.68M+11.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$34.51M-26.0%
ADMA Biologics logo
ADMA BiologicsADMA
$60.07M+63.3%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

$30.8Mebit+
$2.7MDepreciation Depletion & Amortization
=-$28.12M

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's EBITDA?
Absci Corporation (ABSI) reported EBITDA of -$28.12M in Q1 2026.
How has Absci Corporation's EBITDA changed year-over-year?
Absci Corporation's EBITDA decreased by 14.0% year-over-year, from -$24.66M to -$28.12M.
What is the long-term trend for Absci Corporation's EBITDA?
Over 4 years (2021 to 2025), Absci Corporation's EBITDA has grown at a 12.2% compound annual growth rate (CAGR), from -$68.58M to -$108.58M.
What does EBITDA mean?
Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.